Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Potential pathophysiological mechanisms leading to increased COVID-19 susceptibility and severity in obesity
Andrej Belančić, Andrea Kresović, Valentino Rački
Obesity Medicine (2020) Vol. 19, pp. 100259-100259
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Evidence Regarding Vitamin D and Risk of COVID-19 and Its Severity
Joseph Mercola, William B. Grant, Carol L. Wagner
Nutrients (2020) Vol. 12, Iss. 11, pp. 3361-3361
Open Access | Times Cited: 260
COVID-19 and obesity in childhood and adolescence: a clinical review
Carlos Alberto Nogueira‐de‐Almeida, Luíz Antônio Del Ciampo, Ivan Savioli Ferraz, et al.
Jornal de Pediatria (2020) Vol. 96, Iss. 5, pp. 546-558
Open Access | Times Cited: 190
Association of high level gene expression of ACE2 in adipose tissue with mortality of COVID-19 infection in obese patients
Sammy Al‐Benna
Obesity Medicine (2020) Vol. 19, pp. 100283-100283
Open Access | Times Cited: 167
Systemic diseases and the cornea
Ruchi Shah, Cynthia Amador, Kati Tormanen, et al.
Experimental Eye Research (2021) Vol. 204, pp. 108455-108455
Open Access | Times Cited: 78
COVID-19 Pandemic as Risk Factors for Excessive Weight Gain in Pediatrics: The Role of Changes in Nutrition Behavior. A Narrative Review
Hellas Cena, Lauren Fiechtner, Alessandra Vincenti, et al.
Nutrients (2021) Vol. 13, Iss. 12, pp. 4255-4255
Open Access | Times Cited: 77
The triumvirate: why hypertension, obesity, and diabetes are risk factors for adverse effects in patients with COVID-19
Harsh Shah, Md Shahjalal Hossain Khan, Nikhil V. Dhurandhar, et al.
Acta Diabetologica (2021) Vol. 58, Iss. 7, pp. 831-843
Open Access | Times Cited: 70
Gut microbiome dysbiosis and endotoxemia - Additional pathophysiological explanation for increased COVID-19 severity in obesity
Andrej Belančić
Obesity Medicine (2020) Vol. 20, pp. 100302-100302
Open Access | Times Cited: 52
Natural Dietary and Medicinal Plants with Anti-Obesity Therapeutics Activities for Treatment and Prevention of Obesity during Lock Down and in Post-COVID-19 Era
Wenli Sun, Mohamad Hesam Shahrajabian, Qi Cheng
Applied Sciences (2021) Vol. 11, Iss. 17, pp. 7889-7889
Open Access | Times Cited: 41
Good practice statements for antithrombotic therapy in the management of COVID‐19: Guidance from the SSC of the ISTH
Alex C. Spyropoulos, Jean M. Connors, James D. Douketis, et al.
Journal of Thrombosis and Haemostasis (2022) Vol. 20, Iss. 10, pp. 2226-2236
Open Access | Times Cited: 37
Obesity and COVID-19: Mechanistic Insights From Adipose Tissue
Lili Yu, Xiaoying Zhang, Sarah Ye, et al.
The Journal of Clinical Endocrinology & Metabolism (2022) Vol. 107, Iss. 7, pp. 1799-1811
Open Access | Times Cited: 28
Comorbidities of COVID-19 Patients
Radu Silaghi‐Dumitrescu, Iulia Patrascu, Maria Lehene, et al.
Medicina (2023) Vol. 59, Iss. 8, pp. 1393-1393
Open Access | Times Cited: 21
COVID‐19 and obesity in childhood and adolescence: a clinical review
Carlos Alberto Nogueira‐de‐Almeida, Luíz Antônio Del Ciampo, Ivan Savioli Ferraz, et al.
Jornal de Pediatria (Versão em Português) (2020) Vol. 96, Iss. 5, pp. 546-558
Open Access | Times Cited: 49
Incidence and risk factors of COVID-19-like symptoms in the French general population during the lockdown period: a multi-cohort study
Fabrice Carrat, Mathilde Touvier, Gianluca Severi, et al.
BMC Infectious Diseases (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 40
Confounding Factors Influencing the Kinetics and Magnitude of Serological Response Following Administration of BNT162b2
Jean‐Louis Bayart, Laure Morimont, Mélanie Closset, et al.
Microorganisms (2021) Vol. 9, Iss. 6, pp. 1340-1340
Open Access | Times Cited: 39
Obesity and COVID-19 in children and adolescents: a double pandemic.
Ilaria Brambilla, Francesco Delle Cave, Guarracino Carmen, et al.
PubMed (2022) Vol. 93, Iss. S3, pp. e2022195-e2022195
Closed Access | Times Cited: 22
Gut Microbiota and COVID-19: Potential Implications for Disease Severity
Giulia Rocchi, Marta Giovanetti, Francesca Benedetti, et al.
Pathogens (2022) Vol. 11, Iss. 9, pp. 1050-1050
Open Access | Times Cited: 22
Innovative gene therapy strategies for tackling obesity
Motahareh Sheikh‐Hosseini, Mohammad Moarefzadeh, Alyaa Abdulhussein Alsaedi, et al.
Egyptian Journal of Medical Human Genetics (2025) Vol. 26, Iss. 1
Open Access
A multicenter consensus: A role of furin in the endothelial tropism in obese patients with COVID-19 infection
Antoine AbdelMassih, Jianping Ye, Aya Kamel, et al.
Obesity Medicine (2020) Vol. 19, pp. 100281-100281
Open Access | Times Cited: 33
Friend or foe? ACE2 inhibitors and GLP-1R agonists in COVID-19 treatment
Juan Pang, Mingyao Liu, Wenhua Ling, et al.
Obesity Medicine (2021) Vol. 22, pp. 100312-100312
Open Access | Times Cited: 30
Obesity, vitamin D deficiency and old age a serious combination with respect to coronavirus disease-2019 severity and outcome
Hans K. Biesalski
Current Opinion in Clinical Nutrition & Metabolic Care (2020) Vol. 24, Iss. 1, pp. 18-24
Closed Access | Times Cited: 28
COVID-19 and hypertension: is the HSP60 culprit for the severe course and worse outcome?
Hrvoje Jakovac
AJP Heart and Circulatory Physiology (2020) Vol. 319, Iss. 4, pp. H793-H796
Open Access | Times Cited: 27
Glucagon‐like peptide‐1 receptor agonists in the era of COVID‐19: Friend or foe?
Andrej Belančić, Andrea Kresović, Marija Dijan
Clinical Obesity (2021) Vol. 11, Iss. 2
Open Access | Times Cited: 26
Obesity, COVID-19 and Immunotherapy: the Complex Relationship!
Carmine Finelli
Immunotherapy (2020) Vol. 12, Iss. 15, pp. 1105-1109
Open Access | Times Cited: 26
The possible benefits of vitamin D in COVID-19
Danilo Társio Mota Brito, Luiza Helena Ribeiro, Carla Daltro, et al.
Nutrition (2021) Vol. 91-92, pp. 111356-111356
Open Access | Times Cited: 22
Clinical efficacy of weight loss herbal intervention therapy and lifestyle modifications on obesity and its association with distinct gut microbiome: A randomized double-blind phase 2 study
Ming-Zhuo Cao, Chunhua Wei, Mingchun Wen, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top